Leuret, Oriane <br/><br/>
Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria.  [electronic resource] 

 -  Journal of inherited metabolic disease  Nov 2012 
 - 975-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1573-2665 
<br/><br/><label>Standard No.: </label>10.1007/s10545-012-9464-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Biopterins--administration & dosage<br/>Child, Preschool<br/>Female<br/>France<br/>Genotype<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Mutation<br/>Phenylalanine--administration & dosage<br/>Phenylalanine Hydroxylase--genetics<br/>Phenylketonurias--blood<br/>Retrospective Studies<br/>Treatment Outcome